News: Repligen Corp (RGEN.OQ)
RGEN.OQ on NASDAQ Stock Exchange Global Select Market
8.85USD
17 May 2013
8.85USD
17 May 2013
Price Change (% chg)
$-0.03 (-0.34%)
$-0.03 (-0.34%)
Prev Close
$8.88
$8.88
Open
$8.94
$8.94
Day's High
$9.05
$9.05
Day's Low
$8.76
$8.76
Volume
479,972
479,972
Avg. Vol
75,923
75,923
52-wk High
$9.65
$9.65
52-wk Low
$3.73
$3.73
Select another date:
Select another date:
- SmithOnStocks Opines On Recent Biotech News
- Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript
- Repligen Promises To Be A Cash Flow Machine
- Repligen Management Discusses Q4 2012 Results - Earnings Call Transcript
- Warren Isabelle: 2013 Will Be A Stock Picker's Market
- Repligen Is A Buy: You Don't Have To Mine Gold To Make Money In A Gold Rush
Press Releases
- Repligen Reports Third Quarter 2012 Financial Results
- Repligen CEO to Present at Upcoming Investor Conferences
- Repligen To Report Third Quarter of 2012 Financial Results
- Where We Are Headed - New Outlook on Stemcells, Inc. and Repligen Corporation
- Repligen Appoints Jonathan I. Lieber as CFO
- Repligen to Present at Stifel Nicolaus Healthcare Conference 2012
- Repligen Announces Strategic Focus on Bioprocessing Business and Reports Second Quarter 2012 Financial Results
- Repligen To Report Second Quarter of 2012 Financial Results
- Ronald L. Chez Files Amended 13D and Letter to the Board
- Repligen to Present at JMP Securities Healthcare Conference 2012

